Skip to main content

Slovenia Voters Overwhelmingly Approve Medical Cannabis Referendum Measure

(*Editorial note – this article was updated from its original version to reflect updated voting results*)

Voters in Slovenia appear to have overwhelmingly voted in favor of a medical cannabis referendum measure today. Today’s cannabis vote in Slovenia occurred alongside the wider 2024 European election.

With 92.84% of the votes counted, 65.41% answered ‘for’ when asked the question (translated from Slovenian to English), “Should the Republic of Slovenia allow the cultivation and processing of cannabis for medical purposes on its territory?”

The medical cannabis referendum question was one of two cannabis questions placed before Slovenia’s voters. The second one asked the question, “Should the Republic of Slovenia allow the cultivation and possession of cannabis for limited personal use on its territory?”

The personal adult cultivation and use question was passing by a slim margin with 92.74% of the vote counted, with 50.93% of voters answering ‘for’ and 49.07% answering ‘against’ the adult-use measure. With such a razor-thin margin, the vote is still too close to call. Local cannabis advocates are celebrating the results of today’s vote in Slovenia.

“People are clearly not satisfied with this drug policy. However, problems are not solved by the same people who created the problems. If only half of the voters are in favor of greater use of cannabis, it will be a big eavesdrop on the counter-propaganda financed by the Ministry of Health and doctors,” stated Božidar Radišič according to domestic reporting by Delo (translated from Slovenian to English).

Both cannabis referendum measures are consultation referendums and are not binding. What happens after all of the votes are counted and recorded is up to lawmakers in Slovenia.

Limited medical cannabis activity is currently permitted in Slovenia, although the nation’s program is more restrictive compared to other European nations, with countries such as Germany having incorporated a wider list of qualifying conditions, regulated domestic production, and regulated commerce.

Slovenia already serves as an international research and development hub for several large industries, and the favorable medical cannabis production and processing vote combined with an already existing infrastructure makes Slovenia well-positioned to do the same for the emerging international cannabis industry.

“Thanks to researchers and laboratories, Slovenia could become an intellectual superpower in the field of cannabis according to Alex Rogers,” Delo also stated in its original coverage.

Today’s vote in Slovenia comes on the heels of other successful recent cannabis policy modernization efforts in other nations. Last month, South Africa’s President signed a measure that legalized private cannabis cultivation, possession, and use by adults.

On April 1st, 2024 the first provisions of Germany’s adult-use cannabis legalization measure went into effect. Adults in Germany can now cultivate up to three plants in their private residences. Social cannabis clubs are expected to launch in July in Germany, and regional adult-use cannabis commerce pilot trials are expected to begin by the end of the year.

Cannabis is also currently legal for adult use in Uruguay, Canada, Malta, Luxembourg, and in two dozen states in the U.S. Additionally, adult-use cannabis commerce pilot trials are underway in several jurisdictions in the Netherlands and Switzerland.

***

Update: The medical cannabis production measure was officially approved after receiving 66.66% ‘for’ votes and the adult-use measure was also officially approved after receiving 51.53% ‘for’ votes. Voting turnout was roughly 41.3% for both measures.

Germany’s New Per Se Cannabis Driving Law Is The Wrong Approach

One of the most serious topics in cannabis policy modernization discussions is how to mitigate the dangers of people driving under the influence of cannabis. If there is one thing that cannabis opponents and responsible cannabis advocates agree on, it is that no one should operate a motor vehicle on a public roadway when they are intoxicated.

Yet, whereas opponents and supporters can agree on that basic premise, the two sides diverge when it comes to how cannabis DUI enforcement should be handled. In every jurisdiction that has modernized its cannabis policies to permit adult use, cannabis opponents have pushed for enforcement practices that are not backed by science.

Germany is the latest jurisdiction to experience this scenario. Lawmakers in Germany adopted a per se cannabis DUI law this week, and drivers in Germany will now be subjected to a 3.5 ng/mL THC limit.

“The amendment to the Road Traffic Act is intended to introduce a THC (tetrahydrocannabinol) limit in road traffic and a ban on alcohol for cannabis users.” The Bundestag stated on its website.

“According to the new regulation, the limit will be 3.5 nanograms per milliliter in the future. If the limit is exceeded for the first time, there is a risk of a fine of 500 euros and a one-month driving ban.” the Bundestag also stated about the recently adopted measure.

Per se THC DUI limits are a knee-jerk public policy reaction by cannabis opponents. Opponents spend a considerable amount of time falsely hyping up imaginary ‘terror on the roadways’ doomsday scenarios leading up to legalization, including in Germany, and per se THC limits are their ‘solution’ to the imaginary problem that they themselves established using false pretenses.

Unfortunately, per se THC limits often resonate with many members of society due to per se alcohol limits being common, including in Europe. Per se blood alcohol limits in Europe range from zero tolerance in places like Hungary and the Czech Republic to .08 in the United Kingdom. The United States also has a national .08 limit, although state-level limits can vary in some circumstances.

While per se limits for blood alcohol levels are based on sound science, the same is not true for cannabis due to a multitude of factors, not the least of which is how the human body metabolizes THC. The human body does not metabolize alcohol and THC in the same manner.

According to a 2021 analysis conducted in Australia, cannabis impairment can last “between three and 10 hours” when consumption involves “moderate to high doses of the intoxicating component of cannabis, tetrahydrocannabinol (THC).” The analysis involved data from over 80 different studies spanning a period of over 20 years.

THC impairment may only last 3 to 10 hours, but metabolized THC can stay in a person’s system for as long as 100 days, well beyond the window of impairment. Depending on how much THC the user consumed and their metabolism rate, the consumer could easily have more than 3.5 ng/mL of THC in their system for weeks or months into the future.  Those consumers will not be impaired at all, and yet still run afoul of Germany’s new cannabis law.

The 3.5 ng/mL threshold in Germany is completely arbitrary, as there is no sound science demonstrating that such a limit automatically equates to impairment. In fact, a study conducted in Canada in 2019 found “no evidence of increased crash risk in drivers with Δ-9-tetrahydrocannabinol < 5 ng/ml and a statistically non-significant increased risk of crash responsibility (odds ratio = 1.74) in drivers with Δ-9-tetrahydrocannabinol ≥ 5 ng/ml.”

Another study conducted in Canada (2024) involving simulated driving data found that the presence of THC in blood is not predictive of detriments in psychomotor performance. The findings are in line with a separate government-funded study in the U.S. that also found that “there was no correlation between THC (and related metabolites/cannabinoids) in blood, OF [oral fluid], or breath and driving performance.”

“The complete lack of a relationship between the concentration of the centrally active component of cannabis in blood, OF, and breath is strong evidence against the use of per se laws for cannabis.” the researchers stated about the government-funded study. Researchers at Yale University also arrived at the same conclusions in a study in 2021.

Germany’s 3.5 ng/mL threshold will likely put a massive burden on the nation’s court system, with countless drivers being falsely accused of operating a motor vehicle while intoxicated. Offenders will have an affirmative defense and will be able to point out that just because they had THC in their system did not automatically mean that they were impaired at the time in question.

Cases involving those set of circumstances will presumably be disaffirmed, but only after a considerable amount of time and money was wasted for both the accused and the courts.

The cannabis plant is complex and how it interacts with human biology is dynamic. There is no one-size-fits-all approach to cannabis impairment as it pertains to operating motor vehicles on public roadways. Germany would be far wiser to implement a comprehensive approach to determining impairment, including the incorporation of various field sobriety tests.

They are less intrusive and are more effective at spotting actual impairment. Field sobriety tests, combined with public awareness campaigns educating consumers about the dangers of driving while impaired and the benefits of pursuing public transit options, are a much better strategy than per se limits.

Until Germany implements more sensible cannabis DUI laws, consumers in Germany are encouraged to take public transit as much as possible.

Italy’s Push To Ban Hemp Flower Products Is Bad For Public Health Strategies

Cannabis products that are low in THC content, often referred to as ‘cannabis light,’ are very popular throughout Europe. Cannabis light products are derived from the flowers of hemp plants and come in many forms, with CBD products being the most commonly found in the European marketplace.

One country in Europe where cannabis light products are particularly popular is Italy where the nation’s government is pushing for a national ban on such products. Italy’s Ministry of Health tried classifying CBD as a narcotic in October 2020, just to reverse the policy change days after enacting it.

Then, in early 2022, language in a 2018 decree was updated to classify hemp as strictly a medicinal plant, however, cannabis associations sued and the language in the decree was annulled roughly a year after it was adopted. The latest push to ban hemp flowers in Italy is largely led by the country’s Prime Minister. Per Hemp Today:

The Italian government of Prime Minister Giorgia Meloni has taken aim at industrial hemp in legislation that would wipe out CBD and all other products derived from the plant’s flowers.

The proposal would ban hemp flowers from “import, processing, possession, transfer, distribution, trade, transport, dispatch, delivery, sale to the public and for consumption, even in semi-finished, dried or shredded form,” according to language in a draft amendment to country’s controversial Security Bill.

Cannabis is currently legal in Europe for adult use in Malta, Luxembourg, and Germany. All three nations have accepted the reality that people will consume cannabis whether it’s legal to do so or not, and that it is obviously better for adults to consume regulated products instead of unregulated products.

Regulated cannabis products are tested to make sure that they are safe for human consumption, and the same is not true for unregulated cannabis products. Humans consuming unregulated cannabis products, including hemp flowers and products derived from them, is not as good for public health outcomes compared to humans consuming regulated products.

Italy would be wise to reverse course and refrain from its push to ban hemp-derived products. In addition to bans on hemp products being illogical, it likely also violates European law. Hemp businesses have already indicated that they will pursue legal remedies if the ban is enacted.

Leaders in Italy’s hemp industry estimate that the nation is currently home to over 3,000 businesses that employ over 15,000 people.

South Africa’s President Signs ‘Private Setting’ Cannabis Legalization Measure

Back in 2018, South Africa’s Constitutional Court issued a landmark ruling that deemed cannabis prohibition as it pertained to adult individuals to be unconstitutional. The 2018 decision stemmed from a lower court decision in Western Cape in March 2017 which determined that a ban on cannabis use by adults at home was unconstitutional.

The 2018 decision in South Africa left many unknowns, including how much cannabis a person could cultivate and possess in a private setting. The Court largely punted many policy decisions to lawmakers, who then proceeded to drag their feet for several years. Today, after a long delay, South Africa’s President signed a measure to codify the Court’s 2018 decision.

“President Cyril Ramaphosa has signed into law the Cannabis for Private Purposes Act (“CfPPA”). The CfPPA regulates the cultivation, possession, and use of cannabis by adults in a private setting.” The President’s office stated in a press release.

“The consequent regulatory reform enabled by the CfPPA will, amongst others, entirely remove cannabis from the Drugs and Drug Trafficking Act. This will further enable amendment of the Schedules to the Medicines and Related Substances Act and provide for targeted regulatory reform of the Plant Breeders Rights Act and the Plant Improvement Act, as well as other pieces of legislation that require amendment to allow for the industrialisation of the cannabis sector.” the press release also stated.

South Africa joins a growing list of nations that have adopted modernized adult-use cannabis policies. Uruguay legalized cannabis nationally for adults in 2013, with national product sales launching in 2017.

Canada became the second nation to adopt adult-use cannabis legalization in 2018, making it the first G-7 nation to adopt recreational reform. Malta legalized in 2021 followed by Luxembourg in 2023.

Germany is the largest nation to pass a national adult-use legalization measure, with the first provisions of the nation’s CanG law taking effect on April 1st. Social cannabis clubs are expected in Germany in July, and regional adult-use cannabis commerce pilot trials are expected to launch by the end of the year.

South Africa’s recently approved measure does not legalize adult-use cannabis product sales. However, the removal of cannabis from the nation’s Drugs and Drug Trafficking Act is significant.

Somewhat similar to Germany’s recent removal of cannabis from its national Narcotics List, the removal in South Africa will likely have a dramatic impact on its national medical cannabis industry. Researchers estimate that South Africa’s medical cannabis industry has the potential to create a R100 billion-a-year boost to the nation’s economy and create over 130,000 jobs.

Today’s cannabis measure signing in South Africa adds to the growing momentum for global reform.

Major Shift: German Hemp ‘Intoxication Clause’ Expected To End Soon

Cannabis products that contain high percentages of THC generate a lot of headlines in Germany these days, and rightfully so. Germany recently legalized the cultivation, possession, and consumption of high-THC flower by adults, and the nation’s medical cannabis industry continues to thrive as well.

However, Germany’s domestic hemp industry is making strides too, with consumer demand for hemp-derived products trending upward. Some consumers in Germany prefer CBD products with little to no amounts of THC, as well as products derived from hemp containing ‘alternative cannabinoids’ such as delta-8 THC.

Leadership in Germany recently announced that enforcement authority for the “authorization and monitoring of the use of cannabis for scientific purposes” will be vested in the Federal Agency for Food and Agriculture. Cem Özdemir, the current Federal Minister of Food and Agriculture, has indicated that a major hurdle facing Germany’s emerging hemp industry could be going away soon.

“Cem Özdemir, Federal Minister of Food and Agriculture, announced the abolition of the so-called “intoxication clause” at yesterday’s Parliamentary Evening of the Cannabis Industry. This special German rule means that even very low levels of THC in industrial hemp can lead to criminal liability, raids and plant closures.” stated the Cannabis Industry Association (BvCW) in its initial coverage (translated from German to English).

“In conjunction with other bureaucratic hurdles, this has hindered the use and processing of industrial hemp in Germany. This unnecessary competitive disadvantage is now finally being abolished. The cannabis industry association has campaigned intensively for this in recent years.” the Cannabis Industry Association (BvCW) also stated.

“Imagine if dealers and producers of non-alcoholic beer were subjected to raids and punished because they could distill a schnapps from the remaining alcohol. In practice, such a complex extraction does not take place with industrial hemp,” said BvCW managing director Jürgen Neumeyer. “This senseless noise clause has increasingly led to economic damage and bankruptcies in recent years. The abolition is urgently needed and we are therefore very pleased! This is an important step towards re-establishing the German industrial hemp industry. We look forward to a draft from the BMEL and will continue to support the parliamentary process constructively.”

Soon, Germany will launch social cannabis clubs and adult-use cannabis commerce pilot trials. Adult consumers will be able to become members of a social club and/or join a local pilot trial and legally source cannabis products that contain THC.

As previously mentioned, adults in Germany can already cultivate high-THC cannabis in their homes as of April 1st, 2024. Punishing people for cultivating or consuming hemp-derived products is more ridiculous than ever.

Cannabis advocates have long pushed for this type of reform, including in the lead-up to the passage of the new CanG bill. Unfortunately, opponents were able to maintain the status quo under the premise that consumers could make intoxicating products out of hemp.

“If access to THC-containing flowers is to be made possible through clubs and home cultivation anyway, why should anyone go to the trouble of extracting low doses of THC from CBD flowers for several hours in their own home workshop?” Krautinvest.de pointed out in its initial reporting.

“Speaking at the International Cannabis Business Conference Berlin last year, industry veteran and President of EIHA Daniel Kruse said: “I would simply cancel this clause. All stakeholders will advocate for its abolition.” Business of Cannabis stated in its initial reporting.

“The debate about the ‘misuse of hemp’ needs to be brought to an end. Hemp has huge potential if the clause is abolished. Industrial hemp would lead to more sales than medical and recreational put together in Germany.” Daniel Kruse also stated at the International Cannabis Business Conference in Berlin according to Business of Cannabis.

In addition to causing headaches in Germany, the lack of comprehensive hemp and CBD industry reform has also caused similar issues throughout Europe. The European CBD and hemp-derived consumables industries are here to stay, and governments at all levels would be wise to work toward harmonizing related laws, rules, and regulations.

Cannabis Referendums In Slovenia Deserve A Serious Discussion

Slovenia’s voters will decide on two consulting referendum measures on June 9th pertaining to cannabis policy modernization proposals. The referendum questions were approved for voter referral by Slovenia’s National Assembly in April. Neither measure is binding, however, successful votes for either will help further build upon increasing momentum for Slovenian cannabis reform.

One of the consulting referendum measures involves modernizing Slovenia’s medical cannabis policies. Limited medical cannabis commerce and use are already permitted in Slovenia, however, domestic production is not. Patient advocates are seeking to expand the nation’s medical cannabis program to boost domestic production and safe access, increase product variety selection, improve research policies, and expand the list of Slovenia’s qualifying conditions.

The second consulting referendum measure asks voters about the “cultivation and possession of cannabis for limited personal use” by adults. Personal cultivation, possession, and use by adults are already legal in Malta, Luxembourg, and Germany. Courts in other European countries have also issued rulings that provide similar personal cannabis consumer protections.

Cannabis policy modernization proposals in Slovenia are important topics worthy of constructive public policy conversations. Unfortunately, cannabis opponents in Slovenia seem to prefer using delay tactics and spreading incomplete/misleading information.

An example can be found in a recent article published by Slovenia’s National Institute of Public Health in which the entity expresses opposition to cannabis use and reform in general, but does not specifically call out the upcoming referendum votes. Still, the aim of the article is glaringly obvious.

The Institute’s opposition article largely relies on anti-cannabis talking points that have been recycled for decades and completely disregards very important facts and realities, which makes the Institute’s position come across as disingenuous and unauthentic. The article clearly comes across as more of a political document than it does serving as an objective analysis.

The authors of the article begin by oversimplifying the state of Slovenia’s medical cannabis program and disregarding the ineffectiveness of current medical cannabis policies in Slovenia. The article’s authors are presumably mischaracterizing Slovenia’s current medical cannabis policies to distract and/or confuse the nation’s voters, which is a common cannabis opponent tactic deployed all over the globe.

Yes, technically Slovenia currently permits limited medical cannabis use. However, domestic medical cannabis production is currently limited at best in Slovenia, successfully obtaining effective and regulated medical cannabis products is hard for many patients, and a vast majority of the nation’s suffering citizens do not qualify for legal medical cannabis access under the current policies.

Medical cannabis advocates in Slovenia are seeking to implement medical cannabis policies, rules, and regulations similar to what is already in place in many other parts of the European Union. If other EU member nations can successfully expand their domestic medical cannabis programs without significant issues, so can Slovenia.

The Institute’s article places a heavy emphasis on the harms of adolescent use despite the fact that neither of the referendum measures proposes any changes to Slovenia’s cannabis policies that pertain to adolescent use or furnishing cannabis to minors. The ‘what about the children’ talking point is as old as cannabis prohibition itself, and is nothing more than a scare tactic.

Malta, Luxembourg, and Germany now permit adults to cultivate, possess, and consume cannabis in addition to legalized medical use, and there are no reported major issues in those nations pertaining to youth consumption due to the adult-use policy changes.

The same is true for other scare tactic talking points that the Institute incorporated in its article, such as “passive cannabis use” (public use around others) and driving under the influence. Neither referendum measure proposes changes to Slovenia’s public cannabis use or driving under the influence laws. Both would remain prohibited.

A major macro-level reality that the Institute completely disregards in its positions is that there is no proof that cannabis prohibition lowers cannabis consumption rates. Adults are consuming cannabis in Slovenia every day, just as they have done for many years. The Institute would be well served to acknowledge that reality and advocate for regulation and education instead of continuing to metaphorically stick their heads in the sand and pretend that prohibition works.

Leaders in Malta, Luxembourg, and Germany have taken the position that it is better for public health outcomes when cannabis consumers use home-grown and/or regulated cannabis products versus consuming cannabis products that are sourced from criminal enterprises. Leaders in those nations have also taken the position that it is better to stop wasting precious public resources to enforce failed prohibition policies and instead use those same resources to boost fact-based education and other public programs.

It’s unfortunate that in 2024 cannabis opponents would still rather spread incomplete/misinformation to try to maintain the failed status quo rather than have a constructive public conversation about a more sensible, modern approach to cannabis policies.

With that being said, it is up to cannabis advocates in Slovenia to educate themselves about the true facts regarding cannabis, to tell everyone that they know that the consulting referendum votes will be held on June 9th, and inform them about the objective benefits of modernizing Slovenia’s cannabis policies.

Slovenia does not need to reinvent the wheel. Rather, the Central European nation needs to look to some of its continental peers for policy measures that are already succeeding, such as the policies found in Malta, Luxembourg, and Germany. Cannabis opponents in Slovenia largely benefitted for many years from a lack of successful examples from other EU nations. Those days are now gone, and just as modernized cannabis policies are succeeding in other parts of the EU, the same will prove to be true in Slovenia once lawmakers get the country on the right side of history.

Attend Cannabis Europa 2024 In London In June

The emerging legal cannabis industry in Europe continues to experience exponential growth as more nations modernize their cannabis policies and regulations. Germany recently enacted the first provisions of its adult-use legalization measure and more European countries are expected to do the same in the coming years.

In addition to adult-use reform, the legal medical cannabis industry is also continuing to expand across the European continent. The rise of adult-use legalization will obviously impact Europe’s medical cannabis industry to some extent, however, much is still unclear regarding how both sectors of the industry will operate alongside each other in the future.

The remaining years of this decade in Europe will be pivotal for the emerging legal cannabis industry. Now is the time for entrepreneurs and investors to work to gain a meaningful footprint in Europe’s cannabis space.

Industry policies, rules, regulations, and other framework components that are being created and implemented during this crucial period will largely determine what the future of Europe’s cannabis industry looks like for decades to follow.

That is why it is so important for cannabis entrepreneurs, policymakers, and other leaders to network and learn from each other as much as they can right now. A great opportunity to do exactly that is coming to London on June 25-26, 2024, when Cannabis Europa’s flagship event comes back to London.

“We are ultimately trying to change society by bringing about acceptance and accessibility to cannabis in Europe,” stated Stephen Murphy, Co-Founder and CEO of Prohibition Partners at last year’s Cannabis Europa event. It’s a mission that remains true for this year’s event as well.

The venue for the event, the Barbican Centre, is a return to Cannabis Europa’s roots, with the location previously serving as the venue for the first-ever Cannabis Europa conference back in 2018 and the 2023 installment of the conference. The event’s two-day agenda will cover a range of topics. Below is a sampling of the event’s speakers:

  • Boris Jordan – Executive Chairman, Curaleaf
  • Pat Cash – Former Wimbledon Champion
  • Adonis Georgiadis – Minister of Health, Hellenic Republic (Greece)
  • Paul Depla – Mayor of Breda
  • Nikos Beis – CEO & Vice President of the Board, Tikun Olam Europe
  • Katrina Ffrench – Founder & Director, Unjust C.I.C.
  • Dr. Dylan Said – Senior Head, Malta Medicines Authority

Join 1,500+ influential leaders from thriving cannabis companies, investors actively deploying capital into the market, plus key politicians — the crucial combination needed to drive the European cannabis industry and your business forward.

The event will once again be holding a boutique industry expo, showcasing more than 50 leading businesses as the cream of the European cannabis crop, acting as a jumping off point for growing your business in Europe and beyond.

You can find more information about Cannabis Europa, including how to register for the event, at: www.cannabis-europa.com.

Cannabis Shops In Thailand Expected To Close By April 2025

Thailand made a historic shift in cannabis policy in June 2022 by becoming the first country in the Southeast Asia region to remove cannabis from its national narcotics listing. It appears that policy change will be short-lived, with the nation’s prime minister declaring that cannabis will be reclassified as a narcotic by the end of 2024 and that the country’s cannabis shops will be closed by April 2025.

The announcement was not surprising given the number of anti-cannabis talking points that Thailand Prime Minster Srettha Thavisin has offered up since taking office. While not surprising, it is still defeating news for Thailand’s emerging cannabis industry, which has thrived in recent years thanks in large part to the Thailand government’s help.

Every household in the entire country could sign up initially to legally cultivate low-THC cannabis plants, which a reported 1.1 million citizens of Thailand have done. It was the first time in the history of the world that such a public policy was implemented at a national level.

At the time of Thailand’s historic change in 2022, the Public Health Minister indicated that there would be no plant limit for the government’s cultivation program. Thailand’s government also gave away over 1 million cannabis seeds directly to households that signed up. Additionally, the government gave out low-interest loans to help aspiring cultivators get their operations started.

Thailand’s government also launched an app to help streamline the process of people signing up their households to cultivate cannabis. An FAQ public service announcement effort was launched to help people understand the law and cultivation program back then.

A broad spectrum of government agencies in Thailand previously agreed to do their part to push Thailand’s emerging cannabis industry forward. Thailand also released thousands of people serving time for cannabis offenses.

Unfortunately, major changes appear to be on the way. Per Thai Examiner:

An order given by the Prime Minister on Wednesday would close cannabis shops in Thailand by April 1st, 2025. On Wednesday, Srettha Thavisin made it clear he wanted cannabis reclassified as a scheduled narcotic by the end of 2024. It came as a high-powered working group zeroed in on firm plans for a drug crackdown in Thailand. The meeting was attended by three senior ministers, the Prime Minister, and the secretary to the Defence Minister. In short, one of the proposals agreed upon was the internment of drug addicts at a military base. In addition, discretion given to police in relation to small-time users was tightened. The Prime Minister said he wanted to see more vigorous police action in wiping out illegal drug use.

The region in which Thailand is located is home to some of the harshest cannabis public policies and penalties on Earth, with several Southeastern Asian countries still issuing the death penalty for certain cannabis-only offenses.

Thailand’s emerging cannabis industry was estimated to be worth 28 billion Thai baht (€728 million) within the first year of the historic 2022 policy change and was projected to increase to 336 billion baht (€8.7 billion) by 2030 prior to the prime minister’s announcement.

Second Pillar Of German Cannabis Legalization Inches Forward

When lawmakers in Germany agreed to legalize cannabis for adult use they planned on rolling out German legalization in two phases, or ‘pillars.’ The first pillar involved legalizing the cultivation, possession, and consumption of cannabis by adults along with permitting noncommercial cannabis clubs.

The second pillar will involve launching regional adult-use cannabis commerce pilot trials, and according to domestic reporting in Germany, the regulatory body that will oversee the pilot trials was recently identified in a circulated proposal.

A draft regulation is being circulated in German cannabis association circles, and the ministry led by Cem Özdemir (Greens) is proposing that the enforcement authority for the “authorization and monitoring of the use of cannabis for scientific purposes” be vested in the Federal Agency for Agriculture and Food.

“We are hopeful that a practical way will be created to legally sell cannabis products in Germany – at least in some scientific projects,” stated Jürgen Neumeyer from the Cannabis Industry Association according to initial reporting by Spiegel.

“There is great interest among our members,” Neumeyer also stated, “without an opportunity to sell cannabis directly to consumers, we will not be able to push back the black market.”

Whereas the European Union prohibits nationwide recreational cannabis sales, regional adult-use cannabis commerce pilot trials are permitted by the European Union because they are focused on research. Such pilot trials are already underway in Switzerland and the Netherlands, although they are more limited in size and scope compared to what is expected in Germany.

Germany’s regional adult-use cannabis pilot programs cannot launch until rules and regulations are in place, and that cannot happen without a regulatory entity overseeing the nation’s cannabis pilot programs. With that in mind, the proposal for the Federal Agency for Agriculture and Food to be that entity is a significant milestone for Germany’s continued legalization implementation effort.

Cannabis supporters in Germany’s government appear to be pursuing the regulatory route through the Federal Agency for Agriculture and Food rather than pursuing a separate piece of legislation to launch pilot programs. Government officials seem convinced that the agency’s regulatory authority is already established, and that going this route will expedite the launch of pilot trials in Germany.

Meanwhile, the first reading of a ‘readjustment’ measure will occur in the Bundestag this week, with the reading set to occur on Thursday, May 16th, 9:10 p.m.

“Just a few weeks after the adoption of the consumer cannabis law, the coalition factions of the SPD, Alliance 90/The Greens and FDP want to readjust the regulation. The draft law “to amend the Consumer Cannabis Act and the Medical Cannabis Act” is to be discussed in the first reading on Thursday, May 16, 2024 and, after a 30-minute debate, will be referred to the lead health committee for further discussion.” states an announcement on the Bundestag website.

“The coalition factions’ bill “to amend the Road Traffic Act and other road traffic regulations”, which is not yet available but is also up for discussion and is intended to set a cannabis limit in road traffic, should be referred to the Transport Committee.” the Bundestag announcement also states. The announcement also lists the following:

Amendment to the Consumer Cannabis Act
The background to the readjustment is the protocol statement that the federal government made on the Cannabis Act at the meeting of the Federal Council on March 22, 2024. It is said that the changes should take into account the concerns and wishes of the countries. The evaluation provided for in the Consumer Cannabis Act is to be expanded and the control of cultivation associations by the states is to be made more flexible.

In addition, the states should be given room for maneuver when dealing with large-scale cultivation areas. In addition, the Federal Center for Health Education is planning to develop a further training program for addiction prevention specialists in the states and municipalities.

Amendment to the Road Traffic Act
The amendment to the Road Traffic Act is intended to introduce a THC limit (tetrahydrocannabinol) in road traffic and a ban on alcohol for cannabis users.

According to the new regulations, the limit value should in future be 3.5 nanograms per milliliter. If you exceed the limit for the first time, you risk a fine of 500 euros and a one-month driving ban. (hau/04/29/2024)

Noncommercial cannabis clubs, which are part of the first pillar of Germany’s new cannabis law, are still expected to launch in July of this year. A year ago, proposed regulations pertaining to German cannabis clubs were leaked, and included the following:

  • All club properties where cannabis is cultivated and/or stored have to be tightly secured
  • Every club has to have a ‘trained addiction and prevention officer’
  • Must comply with residue limits for pesticides and fertilizers
  • Must track cannabis from seed
  • Annual reporting of crop amounts, including cannabinoid percentage (THC and CBD)
  • Club members only
  • 50 grams per month limit for over 21 years old
  • 30 grams per month limit for 18-20 years old
  • THC percentage cap for 18-20 years old (ten percent THC)
  • Neutral packaging
  • Labeled with specific harvest information

In addition to club provisions, items pertaining to individual use were also reportedly included in the previously leaked draft. Consumption would be prohibited “within a radius of 250 meters from schools, daycare centers, playgrounds, youth facilities or sports facilities” according to the leaked draft regulations. Also, consumption “should also not be permitted in pedestrian zones between 7 a.m. and 8 p.m.”